The capacity of MACC1 to upregulate c-MET expression transcriptionally has been shown in CRC, ovarian cancer (OC), pancreatic cancer (PDAC) and osteosarcoma [4, 81–83]. This evidence concerns the gene MACC1 and ovarian carcinoma.